Treatment differences in adjusted mean change from baseline over @ weeks were nonsignificant for Asthma Control Questionnaire symptom scores ( the primary end point ; GSK@ = -@ , placebo = -@ , P = @ ) and FEV ( GSK@ = -@ , placebo = @ , P = @ ) .